My brother has been told he has end-stage hepatitis C. What does this mean?

Answer From Stacey A. Rizza, M.D.

End-stage hepatitis C means the liver has been severely damaged by the hepatitis C virus. The hepatitis C virus slowly damages the liver over many years, often progressing from inflammation to permanent, irreversible scarring (cirrhosis). Often, people have no signs or symptoms of liver disease or have only mild symptoms for years or even decades until they develop cirrhosis.

Once you have cirrhosis, treatment focuses on keeping the condition from worsening. It may be possible to stop or slow the damage.

Symptoms of end-stage liver disease may include:

  • Easy bleeding or bruising
  • Persistent or recurring yellowing of your skin and eyes (jaundice)
  • Intense itching
  • Abdominal pain
  • Loss of appetite
  • Nausea
  • Swelling due to fluid buildup in your abdomen and legs
  • Problems with concentration and memory

Cirrhosis usually progresses to the point where the liver loses most or all of its function — liver failure. In addition, people with cirrhosis may develop:

  • Bleeding of the digestive (gastrointestinal) tract due to enlarged veins in the tube that connects the throat and stomach (esophagus), a condition known as esophageal varices
  • Brain and nervous system damage due to the buildup of toxins in the bloodstream (hepatic encephalopathy)

Cirrhosis also increases your risk of liver cancer.

The only effective treatment for people with end-stage liver disease is a liver transplant. Chronic hepatitis C virus is the most frequent cause of liver transplantation in the United States. Most people who receive liver transplants for hepatitis C survive for at least five years after their transplants, but almost always hepatitis C virus returns.

If you're diagnosed with hepatitis C or end-stage liver disease, see a doctor who specializes in gastrointestinal diseases or liver diseases (hepatologist). Newer, more-effective hepatitis C treatments can eliminate the virus in many people, reducing the risk of end-stage liver disease.

With

Stacey A. Rizza, M.D.

Get the latest health advice from Mayo Clinic delivered to your inbox.

Sign up for free, and stay up-to-date on research advancements, health tips and current health topics, like COVID-19, plus expert advice on managing your health.

To provide you with the most relevant and helpful information and to understand which information is beneficial, we may combine your e-mail and website usage information with other information we have about you. If you are a Mayo Clinic Patient, this could include Protected Health Information (PHI). If we combine this information with your PHI, we will treat all of that information as PHI, and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of e-mail communications at any time by clicking on the Unsubscribe link in the e-mail.

June 02, 2020 See more Expert Answers